Redpoint Investment Management Pty LTD United Therapeutics Corp Transaction History

Redpoint Investment Management Pty LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$76.06 - $120.81 $766,532 - $1.22 Million	-10,078 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$101.4 - $128.73 $124,620 - $158,209	-1,229 Reduced 10.87%	10,078 $1.1 Million
Q3 2018 Nov 08, 2018	SELL	$113.81 - $129.46 $179,819 - $204,546	-1,580 Reduced 12.26%	11,307 $1.45 Million
Q2 2018 Aug 09, 2018	SELL	$101.14 - $118.31 $1.11 Million - $1.3 Million	-10,984 Reduced 46.01%	12,887 $1.46 Million
Q4 2017 Aug 09, 2018	BUY	$118.58 - $151.28 $2.83 Million - $3.61 Million	23,871	23,871 $3.53 Million

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.